Naples, Italy

Alberto Abbruzzese Saccardi


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Alberto Abbruzzese Saccardi in Cancer Treatment

Introduction

Alberto Abbruzzese Saccardi is an innovative inventor based in Naples, Italy. He has made significant contributions to the field of cancer treatment through his research and inventions. His work focuses on the development of advanced pharmaceutical formulations that utilize nanotechnology.

Latest Patents

One of his notable patents is titled "Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers." This invention describes nanocomplexes, also known as auto-assembling nanoparticles, which comprise bisphosphonates, lipid nanovectors, and inorganic nanovectors. Specifically, the invention details zoledronic acid complexed with calcium phosphate-based nanoparticles, which are mixed with lipidic particles such as liposomes. These nanocomplexes have shown to be effective in vivo as pharmaceutical formulations of bisphosphonates for the treatment or prevention of tumor growth and metastasis. The tumors targeted by this invention can be solid or hematological, including prostate, lung, head/neck, colon, liver, breast, pancreas, kidneys, bladder, and various urogenital tract cancers, as well as multiple myeloma and lymphomas.

Career Highlights

Alberto Abbruzzese Saccardi is associated with Istituti Fisioterapici Ospitalieri, where he continues to advance his research in the field of oncology. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

He has collaborated with notable colleagues such as Giuseppe De Rosa and Michele Caraglia, contributing to the advancement of cancer treatment methodologies.

Conclusion

Alberto Abbruzzese Saccardi's innovative work in developing self-assembling nanoparticles represents a significant advancement in cancer treatment. His contributions have the potential to enhance therapeutic strategies and improve patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…